Dietary approach to attenuate oxidative stress, hypertension, and inflammation in the cardiovascular system

  • Lingyun Wu
    Departments of Anatomy and Cell Biology and Physiology, College of Medicine, and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5; and Plant Biotechnology Institute, National Research Council, Saskatoon, SK, Canada SW9 OW9
  • M. Hossein Noyan Ashraf
    Departments of Anatomy and Cell Biology and Physiology, College of Medicine, and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5; and Plant Biotechnology Institute, National Research Council, Saskatoon, SK, Canada SW9 OW9
  • Marina Facci
    Departments of Anatomy and Cell Biology and Physiology, College of Medicine, and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5; and Plant Biotechnology Institute, National Research Council, Saskatoon, SK, Canada SW9 OW9
  • Rui Wang
    Departments of Anatomy and Cell Biology and Physiology, College of Medicine, and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5; and Plant Biotechnology Institute, National Research Council, Saskatoon, SK, Canada SW9 OW9
  • Phyllis G. Paterson
    Departments of Anatomy and Cell Biology and Physiology, College of Medicine, and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5; and Plant Biotechnology Institute, National Research Council, Saskatoon, SK, Canada SW9 OW9
  • Alison Ferrie
    Departments of Anatomy and Cell Biology and Physiology, College of Medicine, and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5; and Plant Biotechnology Institute, National Research Council, Saskatoon, SK, Canada SW9 OW9
  • Bernhard H. J. Juurlink
    Departments of Anatomy and Cell Biology and Physiology, College of Medicine, and College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK, Canada S7N 5E5; and Plant Biotechnology Institute, National Research Council, Saskatoon, SK, Canada SW9 OW9

書誌事項

公開日
2004-04-21
DOI
  • 10.1073/pnas.0402004101
公開者
Proceedings of the National Academy of Sciences

この論文をさがす

説明

<jats:p>Imbalance between production and scavenging of superoxide anion results in hypertension by the inactivation of nitric oxide, and the increased oxidative stress from the resultant peroxynitrite that is produced promotes inflammatory processes such as atherosclerosis. Induction of phase 2 proteins promotes oxidant scavenging. We hypothesized that intake of dietary phase 2 protein inducers would ameliorate both hypertension and atherosclerotic changes in the spontaneously hypertensive stroke-prone rat. For 5 days/week for 14 weeks, we fed rats 200 mg/day of dried broccoli sprouts that contained glucoraphanin, which is metabolized into the phase 2 protein-inducer sulforaphane (Group A), sprouts in which most of the glucoraphanin was destroyed (Group B), or no sprouts (Group C). After 14 weeks of treatment, no significant differences were seen between rats in Groups B and C. Rats in Group A had significantly decreased oxidative stress in cardiovascular and kidney tissues, as shown by increased glutathione (GSH) content and decreased oxidized GSH, decreased protein nitrosylation, as well as increased GSH reductase and GSH peroxidase activities. Decreased oxidative stress correlated with better endothelial-dependent relaxation of the aorta and significantly lower (20 mm Hg) blood pressure. Tissues from Groups B and C had considerable numbers of infiltrating activated macrophages, indicative of inflammation, whereas animals in Group A had few detectable infiltrating macrophages. There is interest in dietary phase 2 protein inducers as means of reducing cancer incidence. We conclude that a diet containing phase 2 protein inducers also reduces the risk of developing cardiovascular problems of hypertension and atherosclerosis.</jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ